N-[4-[1-[6-(2,2,2-trifluoroethoxy)pyridine-2-carbonyl]piperidin-4-yl]phenyl]-1,8-naphthyridine-4-carboxamide
C28H24F3N5O3 — CID 171681681
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[1-[6-(2,2,2-trifluoroethoxy)pyridine-2-carbonyl]piperidin-4-yl]phenyl]-1,8-naphthyridine-4-carboxamide
N-[4-[1-[6-(2,2,2-trifluoroethoxy)pyridine-2-carbonyl]piperidin-4-yl]phenyl]-1,8-naphthyridine-4-carboxamide (PubChem CID 171681681) has the molecular formula C28H24F3N5O3 and a molecular weight of 535.53 g/mol. Its IUPAC name is N-[4-[1-[6-(2,2,2-trifluoroethoxy)pyridine-2-carbonyl]piperidin-4-yl]phenyl]-1,8-naphthyridine-4-carboxamide.
Molecular Properties
| Compound Name | N-[4-[1-[6-(2,2,2-trifluoroethoxy)pyridine-2-carbonyl]piperidin-4-yl]phenyl]-1,8-naphthyridine-4-carboxamide |
|---|---|
| PubChem CID | 171681681 |
| Molecular Formula | C28H24F3N5O3 |
| Molecular Weight | 535.53 g/mol |
| Exact Mass | 535.18 |
| IUPAC Name | N-[4-[1-[6-(2,2,2-trifluoroethoxy)pyridine-2-carbonyl]piperidin-4-yl]phenyl]-1,8-naphthyridine-4-carboxamide |
| SMILES | O=C(Nc1ccc(C2CCN(C(=O)c3cccc(OCC(F)(F)F)n3)CC2)cc1)c1ccnc2ncccc12 |
| InChI | InChI=1S/C28H24F3N5O3/c29-28(30,31)17-39-24-5-1-4-23(35-24)27(38)36-15-11-19(12-16-36)18-6-8-20(9-7-18)34-26(37)22-10-14-33-25-21(22)3-2-13-32-25/h1-10,13-14,19H,11-12,15-17H2,(H,34,37) |
| InChIKey | GCYVLWJVSZDVNX-UHFFFAOYSA-N |
| XLogP | 5.24 |
| TPSA | 97.31 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 535.53 |
| LogP ≤ 5 | 5.24 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171681681 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.